Eastern Hepatobiliary Surgery Hospital

Running trials

• Not yet recruiting

  Efficacy and Safety of SBRT Plus Gemcitabine, Cisplatin, and Sintilimab as First-Line Treatment for Unresectable Biliary Tract Cancer

  NCT07638501· Phase 2· Source

• Not yet recruiting

  A Trial of Behavioral Intervention on Prognostic Survival of Patients With Unresectable Liver Cancer

  NCT07337031· Source

• Not yet recruiting

  Efficacy and Safety of TT-00420 (Tinengotinib) Tablets Versus Chemotherapy in Patients With Advanced Intrahepatic Cholangiocarcinoma Harboring FGFR2 Fusions/Rearrangements or Mutations

  NCT07328919· Phase 3· Source

• Recruiting

  The Efficacy of Sequential Treatment With Bevacizumab Combined With Atezolizumab in Advanced Liver Cancer With MASLD

  NCT07285850· Phase 2/3· Source

• Recruiting

  Computer-Aided Diagnosis for Hepatocellular Carcinoma Microvascular Invasion

  NCT07170345· Source

• Active, not recruiting

  Study of TT-00420 (Tinengotinib) in Subjects With Cholangiocarcinoma Who Failed or Relapsed to Chemotherapy and FGFR Inhibitor

  NCT06057571· Phase 2· Source

• Active, not recruiting

  Construction of a Recurrence Risk Prediction Model for Liver Resection Based on Drug Sensitivity of Patient-derived Hepatocellular Carcinoma Organoid

  NCT06699524· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Liver and biliary tract cancer5 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Withdrawn

  Second-line Treatment With CAdonilimab and LEnvatinib for Unresectable HCC

  NCT06361758· Phase 2· Source

• Completed

  Vascular Invasion Prediction Via a Multimodal Model Supports Re-staging of Early-stage Hepatocellular Carcinoma

  NCT05540925· Source

Trial sites

• Eastern Hepatobiliary Surgery Hospital7 trials
• Eastern Hepatobiliary Surgery Hospital, Naval Medical University,2 trials

Conditions

Diseases this institution publishes on or runs trials for.

• Liver and biliary tract cancer201 works · 9 trials